*ASTRAZENECA GETS THREE-YEAR REPRIEVE FROM TRUMP PHARMA TARIFFS
$AZN https://t.co/OXQs3bQlPV
@Investingcom
AstraZeneca $AZN Q3 2024 earnings were released today before the market opened:
- Revenue: $13.56B vs $13.09B
- EPS: $1.04 vs $1.03 https://t.co/L9YMcRERaB
@Benzinga
⚠️ JUST IN:
*ASTRAZENECA PULLS COVID VACCINE DUE TO WEAK GLOBAL DEMAND, WEEKS AFTER ADMITTING RARE SIDE EFFECT
$AZN https://t.co/9yqBfFrCIn